{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:03:55Z","timestamp":1774987435108,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The t(12;21)(p13;q22) is the most common chromosomal translocation in pediatric Bcell precursor acute lymphoblastic leukemia (BCP-ALL), occurring in 2-5% of healthy newborns. This alteration generates the\n                    <jats:italic>ETV6::RUNX1<\/jats:italic>\n                    (\n                    <jats:italic>E::R<\/jats:italic>\n                    ) fusion gene, encoding an aberrant transcription factor that is insufficient to directly cause leukemia, but establishes a clinically silent pre-leukemic progenitor not yet fully characterized. We previously showed that E::R expression in the murine pro-B BaF3 cells caused the slowdown of cell cycle progression and increased phospho-histone H2AX levels, both features of Oncogene-Induced Senescence (OIS). This study investigates E::R\u2019s ability to induce senescence in pro-B and immature hematopoietic cells, revealing new therapeutic targets for pre-leukemic cells. We observed that E::R caused a senescence-like phenotype in BaF3 cells, characterized by altered morphology, increased \u03b2-galactosidase activity, elevated reactive oxygen species (ROS) and Senescence-Associated Secretory Phenotype (SASP) factor secretion. It dysregulated genes within the p53 pathway, including senescence-related genes, causing the accumulation of p53 protein and alteration in its post-translational modifications. In E::R positive cells, while p53-mediated cell cycle arrest occurred, apoptosis was impaired, providing a survival advantage under genotoxic stress. Multiple therapeutic approaches targeting these vulnerabilities were tested. Senolytics SSK1 and piperlongumine selectively eliminated E::R+ cells by exploiting elevated \u03b2-gal activity and ROS levels, respectively. TM5441 leveraged caspase-3 inhibitor PAI-1 upregulation to induce apoptosis. Furthermore, using Sca1-E::R transgenic mice, we validated E::R-induced OIS in the pre-leukemic Lin-Sca1+ immature population and observed reduced pre-B colony formation after SSK1 treatment. These findings demonstrate E::R\u2019s dual role in inducing OIS and conferring apoptosis resistance, highlighting the potential of senescence-targeted therapies to prevent leukemia progression and relapse in E::R carriers.\n                  <\/jats:p>","DOI":"10.1038\/s41420-026-03001-5","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:16:13Z","timestamp":1773213373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting oncogene-induced senescence in ETV6::RUNX1 pre-leukemic cells"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4395-0650","authenticated-orcid":false,"given":"Denise","family":"Acunzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayla","family":"Bertagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Risca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Beneforti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Bresolin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidro","family":"S\u00e1nchez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2955-4528","authenticated-orcid":false,"given":"Giovanni","family":"Cazzaniga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Palmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"3001_CR1","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1182\/blood-2017-09-808402","volume":"131","author":"D Sch\u00e4fer","year":"2018","unstructured":"Sch\u00e4fer D, Olsen M, L\u00e4hnemann D, Stanulla M, Slany R, Schmiegelow K, et al. Five percent of healthy newborns have an ETV6-RUNX1 fusion as revealed by DNA-based GIPFEL screening. Blood. 2018;131:821\u20136. https:\/\/doi.org\/10.1182\/blood-2017-09-808402.","journal-title":"Blood"},{"key":"3001_CR2","doi-asserted-by":"publisher","first-page":"e91116","DOI":"10.1371\/journal.pone.0091116","volume":"9","author":"M \u0160korvaga","year":"2014","unstructured":"\u0160korvaga M, Nikitina E, Kube\u0161 M, Ko\u0161\u00edk P, Gajdo\u0161echov\u00e1 B, Leitnerov\u00e1 M, et al. Incidence of common preleukemic gene fusions in umbilical cord blood in Slovak population. PLoS ONE. 2014;9:e91116. https:\/\/doi.org\/10.1371\/journal.pone.0091116.","journal-title":"PLoS ONE"},{"key":"3001_CR3","doi-asserted-by":"publisher","first-page":"35824","DOI":"10.18632\/oncotarget.16211","volume":"8","author":"P Kosik","year":"2017","unstructured":"Kosik P, Skorvaga M, Durdik M, Jakl L, Nikitina E, Markova E, et al. Low numbers of pre-leukemic fusion genes are frequently present in umbilical cord blood without affecting DNA damage response. Oncotarget. 2017;8:35824\u201334. https:\/\/doi.org\/10.18632\/oncotarget.16211.","journal-title":"Oncotarget"},{"key":"3001_CR4","doi-asserted-by":"publisher","first-page":"e0119256","DOI":"10.1371\/journal.pone.0119256","volume":"10","author":"DA Ornelles","year":"2015","unstructured":"Ornelles DA, Gooding LR, Garnett-Benson C. Neonatal infection with species C adenoviruses confirmed in viable cord blood lymphocytes. PloS One. 2015;10:e0119256. https:\/\/doi.org\/10.1371\/journal.pone.0119256.","journal-title":"PloS One"},{"key":"3001_CR5","doi-asserted-by":"publisher","unstructured":"Ford AM, Bennett CA, Price CM, Bruin MCA, Van Wering ER, Greaves M. Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. Proc Natl Acad Sci USA. 1998;95:4584\u20138. https:\/\/doi.org\/10.1073\/pnas.95.8.4584.","DOI":"10.1073\/pnas.95.8.4584"},{"key":"3001_CR6","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/s0140-6736(99)09403-9","volume":"354","author":"JL Wiemels","year":"1999","unstructured":"Wiemels JL, Cazzaniga G, Daniotti M, Eden OB, Addison GM, Masera G, et al. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet Lond Engl. 1999;354:1499\u2013503. https:\/\/doi.org\/10.1016\/s0140-6736(99)09403-9.","journal-title":"Lancet Lond Engl"},{"key":"3001_CR7","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1593\/neo.131310","volume":"15","author":"H-P Kantner","year":"2013","unstructured":"Kantner H-P, Warsch W, Delogu A, Bauer E, Esterbauer H, Casanova E. et al. ETV6\/RUNX1 induces reactive oxygen species and drives the accumulation of DNA damage in B cells. Neoplasia N Y N. 2013;15:1292\u2013300. https:\/\/doi.org\/10.1593\/neo.131310.","journal-title":"Neoplasia N Y N"},{"key":"3001_CR8","doi-asserted-by":"publisher","first-page":"5515","DOI":"10.1182\/blood-2007-10-117150","volume":"111","author":"R Mody","year":"2008","unstructured":"Mody R, Li S, Dover DC, Sallan S, Leisenring W, Oeffinger KC, et al. Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood. 2008;111:5515\u201323. https:\/\/doi.org\/10.1182\/blood-2007-10-117150.","journal-title":"Blood"},{"key":"3001_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000318","volume":"4","author":"J Yu","year":"2020","unstructured":"Yu J, Waanders E, van Reijmersdal SV, Anti\u0107 \u017d, van Bosbeek CM, Sonneveld E, et al. Upfront treatment influences the composition of genetic alterations in relapsed pediatric B-cell precursor acute lymphoblastic leukemia. HemaSphere. 2020;4:e318. https:\/\/doi.org\/10.1097\/HS9.0000000000000318.","journal-title":"HemaSphere"},{"key":"3001_CR10","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1182\/blood.v98.3.558","volume":"98","author":"AM Ford","year":"2001","unstructured":"Ford AM, Fasching K, Panzer-Gr\u00fcmayer ER, Koenig M, Haas OA, Greaves MF. Origins of \u201clate\u201d relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes. Blood. 2001;98:558\u201364. https:\/\/doi.org\/10.1182\/blood.v98.3.558.","journal-title":"Blood"},{"key":"3001_CR11","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1172\/JCI36428","volume":"119","author":"AM Ford","year":"2009","unstructured":"Ford AM, Palmi C, Bueno C, Hong D, Cardus P, Knight D, et al. The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells. J Clin Invest. 2009;119:826\u201336. https:\/\/doi.org\/10.1172\/JCI36428.","journal-title":"J Clin Invest"},{"key":"3001_CR12","doi-asserted-by":"publisher","unstructured":"Wray JP, Deltcheva EM, Boiers C, Richardson S\u0415, Chhetri JB, Brown J, et al. Regulome analysis in B-acute lymphoblastic leukemia exposes Core Binding Factor addiction as a therapeutic vulnerability. Nat Commun 2022;13. https:\/\/doi.org\/10.1038\/s41467-022-34653-3.","DOI":"10.1038\/s41467-022-34653-3"},{"key":"3001_CR13","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/aps.2017.198","volume":"39","author":"X-L Liu","year":"2018","unstructured":"Liu X-L, Ding J, Meng L-H. Oncogene-induced senescence: a double edged sword in cancer. Acta Pharmacol Sin. 2018;39:1553\u20138. https:\/\/doi.org\/10.1038\/aps.2017.198.","journal-title":"Acta Pharmacol Sin"},{"key":"3001_CR14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/s0092-8674(00)81902-9","volume":"88","author":"M Serrano","year":"1997","unstructured":"Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997;88:593\u2013602. https:\/\/doi.org\/10.1016\/s0092-8674(00)81902-9.","journal-title":"Cell"},{"key":"3001_CR15","doi-asserted-by":"publisher","unstructured":"Zhu J, Woods D, McMahon M, Bishop JM. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 1998;12:2997\u20133007. https:\/\/doi.org\/10.1101\/gad.12.19.2997.","DOI":"10.1101\/gad.12.19.2997"},{"key":"3001_CR16","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0014-4827(61)90192-6","volume":"25","author":"L Hayflick","year":"1961","unstructured":"Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961;25:585\u2013621. https:\/\/doi.org\/10.1016\/0014-4827(61)90192-6.","journal-title":"Exp Cell Res"},{"key":"3001_CR17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3390\/biom10030420","volume":"10","author":"M Mijit","year":"2020","unstructured":"Mijit M, Caracciolo V, Melillo A, Amicarelli F, Giordano A. Role of p53 in the regulation of cellular senescence. Biomolecules. 2020;10:420 https:\/\/doi.org\/10.3390\/biom10030420.","journal-title":"Biomolecules"},{"key":"3001_CR18","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/ijc.27316","volume":"130","author":"H Rayess","year":"2012","unstructured":"Rayess H, Wang MB, Srivatsan ES. Cellular senescence and tumor suppressor gene p16. Int J Cancer. 2012;130:1715\u201325. https:\/\/doi.org\/10.1002\/ijc.27316.","journal-title":"Int J Cancer"},{"key":"3001_CR19","doi-asserted-by":"publisher","first-page":"5476","DOI":"10.1038\/sj.onc.1207729","volume":"23","author":"SF Wotton","year":"2004","unstructured":"Wotton SF, Blyth K, Kilbey A, Jenkins A, Terry A, Bernardin-Fried F, et al. RUNX1 transformation of primary embryonic fibroblasts is revealed in the absence of p53. Oncogene. 2004;23:5476\u201386. https:\/\/doi.org\/10.1038\/sj.onc.1207729.","journal-title":"Oncogene"},{"key":"3001_CR20","doi-asserted-by":"publisher","first-page":"11263","DOI":"10.1158\/0008-5472.CAN-07-3016","volume":"67","author":"A Kilbey","year":"2007","unstructured":"Kilbey A, Blyth K, Wotton S, Terry A, Jenkins A, Bell M, et al. Runx2 disruption promotes immortalization and confers resistance to oncogene-induced senescence in primary murine fibroblasts. Cancer Res. 2007;67:11263\u201371. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-3016.","journal-title":"Cancer Res"},{"key":"3001_CR21","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1002\/jcb.26443","volume":"119","author":"G Anderson","year":"2018","unstructured":"Anderson G, Mackay N, Gilroy K, Hay J, Borland G, McDonald A, et al. RUNX-mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins. J Cell Biochem. 2018;119:2750\u201362. https:\/\/doi.org\/10.1002\/jcb.26443.","journal-title":"J Cell Biochem"},{"key":"3001_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.722205","volume":"9","author":"J Yang","year":"2021","unstructured":"Yang J, Liu M, Hong D, Zeng M, Zhang X. The paradoxical role of cellular senescence in cancer. Front Cell Dev Biol. 2021;9:722205. https:\/\/doi.org\/10.3389\/fcell.2021.722205.","journal-title":"Front Cell Dev Biol"},{"key":"3001_CR23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/bjh.16523","volume":"190","author":"L Beneforti","year":"2020","unstructured":"Beneforti L, Dander E, Bresolin S, Bueno C, Acunzo D, Bertagna M, et al. Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche. Br J Haematol. 2020;190:262\u201373. https:\/\/doi.org\/10.1111\/bjh.16523.","journal-title":"Br J Haematol"},{"key":"3001_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/febs.15570","volume":"288","author":"E Gonz\u00e1lez-Gualda","year":"2021","unstructured":"Gonz\u00e1lez-Gualda E, Baker AG, Fruk L, Mu\u00f1oz-Esp\u00edn D. A guide to assessing cellular senescence in vitro and in vivo. FEBS J. 2021;288:56\u201380. https:\/\/doi.org\/10.1111\/febs.15570.","journal-title":"FEBS J"},{"key":"3001_CR25","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.4161\/cc.7.19.6780","volume":"7","author":"JC Acosta","year":"2008","unstructured":"Acosta JC, O\u2019Loghlen A, Banito A, Raguz S, Gil J. Control of senescence by CXCR2 and its ligands. Cell Cycle Georget Tex. 2008;7:2956\u20139. https:\/\/doi.org\/10.4161\/cc.7.19.6780.","journal-title":"Cell Cycle Georget Tex"},{"key":"3001_CR26","doi-asserted-by":"publisher","first-page":"H2102","DOI":"10.1152\/ajpheart.00835.2009","volume":"298","author":"GI Mun","year":"2010","unstructured":"Mun GI, Boo YC. Identification of CD44 as a senescence-induced cell adhesion gene responsible for the enhanced monocyte recruitment to senescent endothelial cells. Am J Physiol Heart Circ Physiol. 2010;298:H2102\u20132111. https:\/\/doi.org\/10.1152\/ajpheart.00835.2009.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3001_CR27","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1158\/1541-7786.MCR-14-0056-T","volume":"12","author":"C Palmi","year":"2014","unstructured":"Palmi C, Fazio G, Savino AM, Procter J, Howell L, Cazzaniga V, et al. Cytoskeletal regulatory gene expression and migratory properties of B-cell progenitors are affected by the ETV6-RUNX1 rearrangement. Mol Cancer Res MCR. 2014;12:1796\u2013806. https:\/\/doi.org\/10.1158\/1541-7786.MCR-14-0056-T.","journal-title":"Mol Cancer Res MCR"},{"key":"3001_CR28","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1158\/0008-5472.CAN-17-0701","volume":"77","author":"G Rodr\u00edguez-Hern\u00e1ndez","year":"2017","unstructured":"Rodr\u00edguez-Hern\u00e1ndez G, Hauer J, Mart\u00edn-Lorenzo A, Sch\u00e4fer D, Bartenhagen C, Garc\u00eda-Ram\u00edrez I, et al. Infection exposure promotes ETV6-RUNX1 precursor B-cell leukemia via impaired H3K4 demethylases. Cancer Res. 2017;77:4365\u201377. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0701.","journal-title":"Cancer Res"},{"key":"3001_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"J-P Copp\u00e9","year":"2010","unstructured":"Copp\u00e9 J-P, Desprez P-Y, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol Mech Dis. 2010;5:99\u2013118. https:\/\/doi.org\/10.1146\/annurev-pathol-121808-102144.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"3001_CR30","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1161\/ATVBAHA.117.309451","volume":"37","author":"DE Vaughan","year":"2017","unstructured":"Vaughan DE, Rai R, Khan SS, Eren M, Ghosh AK. Plasminogen activator inhibitor-1 is a marker and a mediator of senescence. Arterioscler Thromb Vasc Biol. 2017;37:1446\u201352. https:\/\/doi.org\/10.1161\/ATVBAHA.117.309451.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3001_CR31","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.bcp.2018.12.013","volume":"162","author":"T Saleh","year":"2019","unstructured":"Saleh T, Tyutyunyk-Massey L, Murray GF, Alotaibi MR, Kawale AS, Elsayed Z, et al. Tumor cell escape from therapy-induced senescence. Biochem Pharmacol. 2019;162:202\u201312. https:\/\/doi.org\/10.1016\/j.bcp.2018.12.013.","journal-title":"Biochem Pharmacol"},{"key":"3001_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/978-3-030-94804-7_8","volume":"1360","author":"MR Zaidi","year":"2022","unstructured":"Zaidi MR, Liebermann DA. Gadd45 in senescence. Adv Exp Med Biol. 2022;1360:109\u201316. https:\/\/doi.org\/10.1007\/978-3-030-94804-7_8.","journal-title":"Adv Exp Med Biol"},{"key":"3001_CR33","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/acel.12060","volume":"12","author":"V Gambino","year":"2013","unstructured":"Gambino V, De Michele G, Venezia O, Migliaccio P, Dall\u2019Olio V, Bernard L, et al. Oxidative stress activates a specific p53 transcriptional response that regulates cellular senescence and aging. Aging Cell. 2013;12:435\u201345. https:\/\/doi.org\/10.1111\/acel.12060.","journal-title":"Aging Cell"},{"key":"3001_CR34","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","volume":"28","author":"A Hernandez-Segura","year":"2018","unstructured":"Hernandez-Segura A, Nehme J, Demaria M. Hallmarks of cellular senescence. Trends Cell Biol. 2018;28:436\u201353. https:\/\/doi.org\/10.1016\/j.tcb.2018.02.001.","journal-title":"Trends Cell Biol"},{"key":"3001_CR35","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/978-1-4419-7002-2_10","volume":"694","author":"F Debacq-Chainiaux","year":"2010","unstructured":"Debacq-Chainiaux F, Boilan E, Dedessus Le Moutier J, Weemaels G, Toussaint O. p38(MAPK) in the senescence of human and murine fibroblasts. Adv Exp Med Biol. 2010;694:126\u201337. https:\/\/doi.org\/10.1007\/978-1-4419-7002-2_10.","journal-title":"Adv Exp Med Biol"},{"key":"3001_CR36","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1038\/onc.2016.502","volume":"36","author":"M Fischer","year":"2017","unstructured":"Fischer M. Census and evaluation of p53 target genes. Oncogene. 2017;36:3943\u201356. https:\/\/doi.org\/10.1038\/onc.2016.502.","journal-title":"Oncogene"},{"key":"3001_CR37","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/sj.cdd.4401908","volume":"13","author":"JE Chipuk","year":"2006","unstructured":"Chipuk JE, Green DR. Dissecting p53-dependent apoptosis. Cell Death Differ. 2006;13:994\u20131002. https:\/\/doi.org\/10.1038\/sj.cdd.4401908.","journal-title":"Cell Death Differ"},{"key":"3001_CR38","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1038\/onc.2009.101","volume":"28","author":"K Wolyniec","year":"2009","unstructured":"Wolyniec K, Wotton S, Kilbey A, Jenkins A, Terry A, Peters G, et al. RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress. Oncogene. 2009;28:2502\u201312. https:\/\/doi.org\/10.1038\/onc.2009.101.","journal-title":"Oncogene"},{"key":"3001_CR39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/jb\/mvu040","volume":"156","author":"G Harada","year":"2014","unstructured":"Harada G, Neng Q, Fujiki T, Katakura Y. Molecular mechanisms for the p38-induced cellular senescence in normal human fibroblast. J Biochem (Tokyo). 2014;156:283\u201390. https:\/\/doi.org\/10.1093\/jb\/mvu040.","journal-title":"J Biochem (Tokyo)"},{"key":"3001_CR40","doi-asserted-by":"publisher","first-page":"7666","DOI":"10.1093\/nar\/gku501","volume":"42","author":"J Loughery","year":"2014","unstructured":"Loughery J, Cox M, Smith LM, Meek DW. Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters. Nucleic Acids Res. 2014;42:7666\u201380. https:\/\/doi.org\/10.1093\/nar\/gku501.","journal-title":"Nucleic Acids Res"},{"key":"3001_CR41","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/cdd.2017.143","volume":"25","author":"C Castrogiovanni","year":"2018","unstructured":"Castrogiovanni C, Waterschoot B, De Backer O, Dumont P. Serine 392 phosphorylation modulates p53 mitochondrial translocation and transcription-independent apoptosis. Cell Death Differ. 2018;25:190\u2013203. https:\/\/doi.org\/10.1038\/cdd.2017.143.","journal-title":"Cell Death Differ"},{"key":"3001_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.17179\/excli2015-561","volume":"14","author":"A Montecucco","year":"2015","unstructured":"Montecucco A, Zanetta F, Biamonti G. Molecular mechanisms of etoposide. EXCLI J. 2015;14:95\u2013108. https:\/\/doi.org\/10.17179\/excli2015-561.","journal-title":"EXCLI J"},{"key":"3001_CR43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/s1097-2765(01)00176-9","volume":"7","author":"DM Keller","year":"2001","unstructured":"Keller DM, Zeng X, Wang Y, Zhang QH, Kapoor M, Shu H, et al. A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1. Mol Cell. 2001;7:283\u201392. https:\/\/doi.org\/10.1016\/s1097-2765(01)00176-9.","journal-title":"Mol Cell"},{"key":"3001_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aav5078","volume":"5","author":"Y Ao","year":"2019","unstructured":"Ao Y, Zhang J, Liu Z, Qian M, Li Y, Wu Z, et al. Lamin A buffers CK2 kinase activity to modulate aging in a progeria mouse model. Sci Adv. 2019;5:eaav5078. https:\/\/doi.org\/10.1126\/sciadv.aav5078.","journal-title":"Sci Adv"},{"key":"3001_CR45","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41422-020-0314-9","volume":"30","author":"Y Cai","year":"2020","unstructured":"Cai Y, Zhou H, Zhu Y, Sun Q, Ji Y, Xue A, et al. Elimination of senescent cells by \u03b2-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice. Cell Res. 2020;30:574\u201389. https:\/\/doi.org\/10.1038\/s41422-020-0314-9.","journal-title":"Cell Res"},{"key":"3001_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2023.111888","volume":"217","author":"AN Rad","year":"2024","unstructured":"Rad AN, Grillari J. Current senolytics: mode of action, efficacy and limitations, and their future. Mech Ageing Dev. 2024;217:111888. https:\/\/doi.org\/10.1016\/j.mad.2023.111888.","journal-title":"Mech Ageing Dev"},{"key":"3001_CR47","doi-asserted-by":"publisher","unstructured":"Schneider DJ, Chen Y, Sobel BE. The effect of plasminogen activator inhibitor type 1 on apoptosis. Thromb Haemost. 2008;100:1037\u201340. https:\/\/doi.org\/10.1160\/TH08-04-0234.","DOI":"10.1160\/TH08-04-0234"},{"key":"3001_CR48","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.semcancer.2011.09.013","volume":"21","author":"R Saab","year":"2011","unstructured":"Saab R. Senescence and pre-malignancy: how do tumors progress?. Semin Cancer Biol. 2011;21:385\u201391. https:\/\/doi.org\/10.1016\/j.semcancer.2011.09.013.","journal-title":"Semin Cancer Biol"},{"key":"3001_CR49","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.exphem.2009.09.002","volume":"37","author":"Y-Y Wang","year":"2009","unstructured":"Wang Y-Y, Cen J-N, He J, Shen H-J, Liu D-D, Yao L, et al. Accelerated cellular senescence in myelodysplastic syndrome. Exp Hematol. 2009;37:1310\u20137. https:\/\/doi.org\/10.1016\/j.exphem.2009.09.002.","journal-title":"Exp Hematol"},{"key":"3001_CR50","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1038\/sj.onc.1210950","volume":"27","author":"S Courtois-Cox","year":"2008","unstructured":"Courtois-Cox S, Jones SL, Cichowski K. Many roads lead to oncogene-induced senescence. Oncogene. 2008;27:2801\u20139. https:\/\/doi.org\/10.1038\/sj.onc.1210950.","journal-title":"Oncogene"},{"key":"3001_CR51","doi-asserted-by":"publisher","first-page":"323","DOI":"10.37349\/etat.2021.00049","volume":"2","author":"D Parama","year":"2021","unstructured":"Parama D, Rana V, Girisa S, Verma E, Daimary UD, Thakur KK, et al. The promising potential of piperlongumine as an emerging therapeutics for cancer. Explor Target Anti-Tumor Ther. 2021;2:323\u201354. https:\/\/doi.org\/10.37349\/etat.2021.00049.","journal-title":"Explor Target Anti-Tumor Ther"},{"key":"3001_CR52","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.bbrc.2014.08.131","volume":"452","author":"S-S Han","year":"2014","unstructured":"Han S-S, Han S, Kamberos NL. Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance. Biochem Biophys Res Commun. 2014;452:669\u201375. https:\/\/doi.org\/10.1016\/j.bbrc.2014.08.131.","journal-title":"Biochem Biophys Res Commun"},{"key":"3001_CR53","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics J Integr Biol. 2012;16:284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"Omics J Integr Biol"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03001-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03001-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03001-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:21:59Z","timestamp":1774984919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03001-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3001"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03001-5","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The investigation was conducted in accordance with the ethical standards of the Declaration of Helsinki, and with national and international guidelines. Animal testing has been conducted following the current European and National Legislation (notification 13 2023, protocol FB7CC.N.S9G released by the Italian Ministry of Health) in compliance with the Animal Welfare Organisation of the University of Milano-Bicocca.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"145"}}